Gene · 382
ARF6: ARF GTPase 6
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. ARF6: ARF GTPase 6. Genes, record 382. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/382
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P62330 | ADP-ribosylation factor 6 | 175 | 20 | Ensembl, GeneID, HGNC |
Source UniProt
Patents41
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 3875 | P62330 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 3875 | P62330 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 3227 | P62330 | Espacenet |
| EP 4484957 A1 | 2025-01-01 | 9 | P62330 | Espacenet |
| JP 2024123008 A | 2024-09-10 | 4790 | P62330 | Espacenet |
| WO 2023162878 A | 2023-08-31 | 9 | P62330 | Espacenet |
| JP 2023064789 A | 2023-05-12 | 73 | P62330 | Espacenet |
| WO 2023074712 A | 2023-05-04 | 19 | P62330 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 3227 | P62330 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 106198 | P62330 | Espacenet |
1 to 10 of 41
See all 41 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,492
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ARF6 papers | Newest fiscal year |
|---|---|---|---|
| ZIABC007365 | Regulation of ADP-ribosylation factor | 25 | 2025 |
| R01DK064380 | Molecular Mechanisms Regulating Epithelial Cell Apical Polarity and Ciliogenesis | 10 | 2025 |
| R01HL016037 | Molecular Regulation of Cardiovascular 7 TM Receptors | 8 | 2025 |
| T32HL007576 | Training in Cardiovascular Research | 8 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 7 | 2025 |
| P30DK058404 | Molecular and Cellular Basis for Digestive Diseases | 7 | 2025 |
| P30DK084567 | Mayo Center for Cell Signaling in Gastroenterology | 6 | 2025 |
| ZIAHD001607 | Protein Trafficking In The Endosomal-Lysosomal System | 6 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| P30CA036727 | Buffett Cancer Center Support Grant | 5 | 2025 |
1 to 10 of 2,492Source NIH's project files
See all 2,492 nih grantsPapers3,632
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A founder population reveals genetic variation with major effect on serious mental illness. | medRxiv | 2026 | 42818201 | PubTator, text mining | PubMed |
| The miR167-ARF8 module integrates HSFA1-HSFA2 and RVE4/8-ERF53/54 transcriptional cascades to enhance plant thermotolerance. | Plant Cell | 2026 | 42798235 | PubTator, text mining | PubMed |
| A biophysical hypothesis for compartment-specific conformational states of the IQSEC2 intrinsically disordered protein. | Biophys J | 2026 | 42706723 | PubTator, text mining | PubMed |
| Membrane engagement by the HLA-A cytoplasmic tail regulates endocytosis and surface retention. | Cell Rep | 2026 | 42690931 | PubTator, text mining | PubMed |
| IQSEC2 and ARF1 are involved in the development of the dentate gyrus. | Biochim Biophys Acta Gen Subj | 2026 | 42685987 | PubTator, text mining | PubMed |
| Targeting ARF6-SUCNR1 Axis: Antisense Oligonucleotide Adjuvants for Neutrophil Immunometabolism. | Int J Mol Sci | 2026 | 42589657 | PubTator, text mining | PubMed |
| Macropinocytosis of Amyloid Precursor Protein Is Regulated by the Recruitment and Activity of Fe65, Arf6 and Rho GTPases. | Cells | 2026 | 42587775 | PubTator, text mining | PubMed |
| SNAI1 ablation alters integrin-mediated adhesion and endocytic fate. | Cell Death Dis | 2026 | 42586969 | PubTator, text mining | PubMed |
| The Potential Target Value of ADP-Ribosylation Factor 6 in Insulin Secretion Regulation and the Treatment of Metabolic Disorders. | Metabolites | 2026 | 42506459 | PubTator, text mining | PubMed |
| Transcriptomic profiling of an in vivo diffuse large B-cell lymphoma model reveals molecular programs underlying CNS dissemination. | Ann Hematol | 2026 | 42380537 | PubTator, text mining | PubMed |
1 to 10 of 3,632
See all 3,632 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/382
GET https://conductscience.org/api/genes/v1/382/patents?page=2